Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 1NETWORK 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 5Sarcoma 2Genitourinary 2Dermatologic 2Thoracic 1Head & Neck 1Gynecologic 1CNS 1Breast 1

Conditions

Melanoma 44Brain Neoplasms 22Carcinoma, Renal Cell 10Neoplasm Metastasis 9Sarcoma 7Lung Neoplasms 7Carcinoma, Non-Small-Cell Lung 7Breast Neoplasms 7Uveal Melanoma 5Gastrointestinal Neoplasms 4Small Cell Lung Carcinoma 3Kidney Neoplasms 3Colorectal Neoplasms 3Carcinoma, Merkel Cell 3Urinary Bladder Neoplasms 2Thyroid Neoplasms 2Spinal Cord Compression 2Skin Neoplasms 2Prostatic Neoplasms 2Pancreatic Neoplasms 2Neoplasms 2Head and Neck Neoplasms 2Colonic Neoplasms 2Carcinoma, Transitional Cell 2Uterine Cervical Neoplasms 1Testicular Neoplasms 1Stomach Neoplasms 1Recurrence 1Rectal Neoplasms 1Radiation Injuries 1

Interventions

pembrolizumab 6cemiplimab 3Cyclophosphamide 3temsirolimus 2palbociclib 2cediranib 2Therapeutics 2Radiotherapy 2Radiosurgery 2Psychiatric Rehabilitation 2Paclitaxel 2Oxaliplatin 2Nivolumab 2Methods 2Magnetic Resonance Spectroscopy 2Leucovorin 2Gemcitabine 2Fluorouracil 2Drug Therapy 2Docetaxel 2Cisplatin 2Capecitabine 2Biological Therapy 22,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide 2ulixertinib 1trastuzumab biosimilar HLX02 1trametinib 1tanespimycin 1sonidegib 1sargramostim 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Colonic Neoplasms × Radiosurgery × Dermatologic × Clear all
NCT04498767 2024-08-26

OligoRARE

European Organisation for Research and Treatment of Cancer - EORTC

Phase NA Recruiting
200 enrolled
DermatologicGastrointestinalGenitourinaryHead & NeckSarcoma

Urinary Bladder Neoplasms, Colonic Neoplasms, Esophageal Neoplasms, Head and Neck Neoplasms, Kidney Neoplasms, Melanoma, Pancreatic Neoplasms, Sarcoma, Skin Neoplasms, Stomach Neoplasms

NCT00587964 2016-02-22

Phase II Trial of Stereotactic Radiosurgery Boost Following Surgical Resection for Brain Metastases

Memorial Sloan Kettering Cancer Center

Phase 2 Completed
51 enrolled 6 charts
BreastCNSDermatologicGastrointestinalGenitourinaryGynecologicSarcomaThoracic

Urinary Bladder Neoplasms, Brain Neoplasms, Breast Neoplasms, Uterine Cervical Neoplasms, Colonic Neoplasms, Lung Neoplasms, Melanoma, Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Rectal Neoplasms, Sarcoma, Testicular Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡